Literature DB >> 32767828

Cascade Programming for 10 kHz Spinal Cord Stimulation: A Single Center Case Series of 114 Patients With Neuropathic Back and Leg Pain.

Adnan Al-Kaisy1, Jonathan Royds1, Omar Al-Kaisy1, Stefano Palmisani1, David Pang1, Tom Smith1, Nick Padfield1, Stephany Harris1, Katie Markham1, Samuel Wesley1, Thomas Yearwood1.   

Abstract

OBJECTIVE: Ten kilohertz spinal cord stimulation (SCS) is usually initiated in a single-bipolar configuration over the radiological reference point T9/T10 intervertebral disc space for neuropathic back and leg pain. Cascade is a duty-cycled, multi-bipolar contact configuration across an entire eight-contact lead. Potential advantages by using a broader area of SCS coverage include mitigation against minor lead migration and a reduction in the need for reprogramming. We report here the results of a retrospective case series of 114 patients using Cascade.
MATERIALS AND METHODS: Retrospective data were collected over two years. We selected patients with neuropathic back with or without/leg pain who had a trial of SCS. Pain assessments using Numerical Rating Scales (NRS) and Patient Global Impression of Change (PGIC) scores were collected at baseline, six months, and last follow-up beyond 12 months (mean 15.1 months). Patients were programmed with 10 kHz SCS using Cascade during the trial, which was continued unless reporting inadequate pain relief. Morbidity and deviations from Cascade programming were also obtained.
RESULTS: At six months, 87 of 97 (90.6%) patients with active devices were using Cascade and 58 of 72 (81%) patients at the last follow-up >12 months. There was a significant reduction in back NRS (8.3 vs. 3.9 [p < 0.0001], N = 97) and leg pain (7.53 vs. 3.83 [p < 0.0001], N = 77) at 6 months and last follow-up >12 months back (8.3 vs. 3.95 [p < 0.0001] N = 72), leg (7.53 vs. 3.534 [p < 0.0001], N = 58). The PGIC score was 6 of 7 or all of 7 in 72% of patients (70/97) at six months and in 68% (49/72) of patients at the last follow-up beyond 12 months.
CONCLUSION: Cascade is an effective programming methodology that may have benefits over a single-bipole configuration for 10 kHz SCS, particularly during a trial of stimulation. Results from this study suggest it is a durable program for patients with neuropathic back and leg pain.
© 2020 International Neuromodulation Society.

Entities:  

Keywords:  Casacde; Chronic Pain; GSTT; Guy's & St Thomas' NHS Foundation Trust; HF10; High-frequency; Neuromodulation; PANARC; Programming; Programming Optimisation; SCS; Spinal Cord Stimulation

Mesh:

Year:  2020        PMID: 32767828     DOI: 10.1111/ner.13219

Source DB:  PubMed          Journal:  Neuromodulation        ISSN: 1094-7159


  4 in total

1.  10 kHz Spinal Cord Stimulation for the Treatment of Failed Back Surgery Syndrome with Predominant Leg Pain: Results from a Prospective Study in Patients from the Dutch Healthcare System.

Authors:  Jan Willem Kallewaard; Ismail Gültuna; Vincent Hoffmann; Lars Elzinga; Renate Munnikes; Lisette Verbrugge; Veerle Minne; Pascalle Reiters; Jeyakumar Subbaroyan; Angela Santos; Anand Rotte; David Caraway
Journal:  Pain Pract       Date:  2020-12-22       Impact factor: 3.183

2.  Health-Care Utilization and Outcomes with 10 kHz Spinal Cord Stimulation for Chronic Refractory Pain.

Authors:  Mayank Gupta; Mahoua Ray; Nicole Ladesich; Akshat Gupta
Journal:  J Pain Res       Date:  2021-12-02       Impact factor: 3.133

Review 3.  A Call to Action Toward Optimizing the Electrical Dose Received by Neural Targets in Spinal Cord Stimulation Therapy for Neuropathic Pain.

Authors:  Krishnan Chakravarthy; Rajiv Reddy; Adnan Al-Kaisy; Thomas Yearwood; Jay Grider
Journal:  J Pain Res       Date:  2021-09-07       Impact factor: 2.832

4.  Efficacy and Safety of 10 kHz Spinal Cord Stimulation Using Cervical and Thoracic Leads: A Single-Center Retrospective Experience.

Authors:  Gernot Surges; Joachim Paulus; Theresa Blaß; Kerstin Mendryscha; Martin Bettag; Anand Rotte
Journal:  Pain Ther       Date:  2021-07-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.